EBS Financial Facts

Interest income: 113K
Product sales: 132.65M
See Full Income Statement

Deferred revenue, current portion: 7.94M
Income tax receivable, net: -27.03M
See Full Balance Sheet

Emergent BioSolutions, Inc. (EBS) Earnings

  |   Expand Research on EBS
Next EPS Date 6/1/16 *Est. EPS Growth Rate +16.4% *Last Qtr.
Average EPS % Beat Rate +42.8% Revenue Growth Rate +21.8% *Last Qtr.
Average % Move 1-Wk after EPS +1.9% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
2/25/16 Q415 $0.78$0.70 +$0.08$168.1M$168.07M N/A Details
11/5/15 Q315 $0.83$0.55 +$0.28$164.9M$151.42M = Details
3/5/15 Q115 $0.75$0.69 +$0.06$148M$147M = Details
11/6/14 Q414 $0.67$0.52 +$0.15$138M$126.9M = Details
8/6/15 Q215 $0.36$0.18 +$0.18$126.1M$114.25M = Details
3/8/12 Q411 $0.78$0.72 +$0.06$107.95M$109.32M = Details
8/7/14 Q214 $0.13$0.32 -$0.19$110.3M$109.25M Details
3/10/11 Q410 $0.78$0.67 +$0.11$103.2M$102.03M = Details